Skip to main content
NIH funding notice RFA-MH-20-115

Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed)

Closed on May 2, 2019.

Posted
February 27, 2019
Close date
May 2, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,609,455 in first-year total cost, median $232,830.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-M (05)]7

Most frequent institutions

  1. BAYLOR COLLEGE OF MEDICINE1
  2. RUSH UNIVERSITY MEDICAL CENTER1
  3. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
  4. UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
  5. UNIVERSITY OF MINNESOTA1
Competing awards under RFA-MH-20-115 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020cART effects on glial cells1R21MH122241-01AL-HARTHI, LENARUSH UNIVERSITY MEDICAL CENTER, IL$235,500ZMH1
2020Collaborative HIV Investigations of Antiretroviral Neuropsychiatric Toxicities in Zambia (CHANTZ): Protease Inhibitor Impact on Pediatric Cerebrovasculature and Mood1R21MH122238-01BIRBECK, GRETCHEN L.POTCHEN, MICHAEL JAMESUNIVERSITY OF ROCHESTER, NY$232,830ZMH1
2020Novel role of inflammasome activation in ART neurotoxicity1R21MH122235-01TOBOREK, MICHALUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$230,250ZMH1
2019Functional impact of antiretroviral drugs on human neuronal subtypes1R21MH122239-01CHRISTIAN, KIMBERLYSU, YIJINGUNIVERSITY OF PENNSYLVANIA, PA$243,000ZMH1
2019Pathogenic Linking of HIV Integrase Inhibitors, Folate Receptors, and Cerebral Folate Deficiency1R21MH122252-01CABRERA, ROBERT MBAYLOR COLLEGE OF MEDICINE, TX$240,000ZMH1
2019Antiretroviral Drug-Induced Changes in Synapses between Human iPSC-Derived Cortical Neurons to Assess Risk and Mechanisms of Neuropsychiatric Adverse Effects1R21MH122193-01THAYER, STANLEY AUNIVERSITY OF MINNESOTA, MN$231,000ZMH1
2019Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity1R21MH122243-01LETENDRE, SCOTT LUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$196,875ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-20-115: Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience